Modulation of human chondrocyte metabolism by recombinant human interferon

Osteoarthritis and Cartilage

Volumn 8, Issue 6, 2000, Pages 474-482

  Henrotin, Y E ^a,b   Zheng, S X ^a   Labasse, A H ^a   Deby, G P ^b   Crielaard, J M R ^a   Reginster, J Y L ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chondrocytes; Cytokines; Interferon; Osteoarthritis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; N(G) METHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEOGLYCAN; STROMELYSIN;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; COMPETITIVE INHIBITION; CONTRAST ENHANCEMENT; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATORY CELL; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPECTROPHOTOMETRY; T LYMPHOCYTE ACTIVATION;

EID: 0034533367     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1999.0323     Document Type: Article

References (56)

1. Synovial fluid concentration of five different cytokines in rheumatic diseases
2. Determination of cytokines in synovial fluids: Correlation with diagnosis and histomorphological characteristics of synovial tissue
3. T cells and T-cell cytokines transcripts in the synovial membrane in patients with osteoarthritis
4. Suppression of bacterial cell-wall-induced polyarthritis by recombinant gamma interferon
5. Cytokine modulation of bacterial cell wall induced arthritis
6. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon gamma
7. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis
8. Therapy for systemic juvenile rheumatoid arthritis with gamma-interferon: A pilot study of nine patients
9. Interferon gamma in rheumatoid arthritis: A double-blind study comparing human recombinant interferon gamma with placebo
10. Transcriptional modulation of cartilage-specific collagen gene expression by interferon γ and tumour necrosis factor α in cultured human chondrocytes
11. Modulation of human chondrocyte metabolism by recombinant human interferon gamma: In-vitro effects on basal and IL-1 stimulated proteinase production, cartilage degradation and DNA synthesis
12. Production of hydrogen peroxide by rabbit articular chondrocytes
13. Influence of gamma-interferon on synovial fibroblast-like cells. The induction and inhibition of collagen synthesis
14. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy
15. Interferon-gamma increases human neutrophil-mediated cartilage proteoglycan degradation
16. Expression of ICAM-1 on intact cartilage and isolated chondrocytes
17. Immune interferon supresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes
18. Effects of associated cytokines (IL-1, TNF-α, IFN-γ, and TGF-β) on collagen and glycosaminoglycan production by cultured human synovial cells
19. Effect of tumor necrosis factor α and γ-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes
20. Recombinant murine interferon gamma inhibits the fusion of mouse alveolar macrophages in vitro but stimulates the formation of osteoclast-like cells on implanted bone particles in mice in vivo
21. Interferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria
22. Interleukin-1 and osteoarthritis
23. Biochemical factors in joint articular tissue degradation in osteoarthritis
24. 2
25. Role of cytokines in osteoarthritis: Comparative effects of interleukin 1 and transforming growth factor-β on cultured rabbit articular chondrocytes
26. 2 production by human articular chondrocytes
27. Effects of exogenous IL-1β, TNFα, IL-6, IL-8 and LIF on cytokine production by human articular chondrocytes
28. 2
29. Effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1beta production in human monocytes and neutrophils
30. Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritic synovium and synovial fibroblasts
31. 2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta
32. Modulation of interleukin-1 receptor expression by transforming growth factor-b in cultured rabbit articular chondrocytes: Analysis by reverse transcription-polymerase chain reaction
33. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: A comparative study with rat chondrocytes and entities
34. Radioimmunoassay of human proteoglycans
35. The presence of cartilage-like proteoglycan in the adult meniscus
36. Chemistry of human articular cartilage
37. A method for producing specific antisera with small doses of immunogen
38. 15N) nitrate in biological fluids
39. 2 production
40. A simple, rapid, and sensitive DNA assay procedure
41. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4
42. Cytokine mRNA repertoire of articular arthritic patients, infants, and neonatal mice
43. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritis synoviocytes. Regulation by IFNγ and IL-4
44. Regulation of distinct steps of angiogenesis by different angiogenic molecules
45. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I inteleukin soluble receptor
46. Anticytokine treatment of established type II collagen-induced arthritis in DBA1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1ra
47. Prevention of murine collagen-induced arthritis in the knee of ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee
48. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patient rheumatoid arthritis
49. Pro-and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats
50. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: Prevention of osteoarthritis progression
51. Immunoregulatory role of interleukin 10 in rheumatoid arthritis
52. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4
53. Differential induction of stromelysin mRNA by bovine articular chondrocytes treated with interferon-γ and interleukin-1α
54. Inhibition of interleukin-1-induced collagenase production in human articular chondrocytes in vitro by recombinant human interferon gamma
55. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1
56. Nitric oxide activates metalloprotease enzymes in articular cartilage